Anzeige
Mehr »
Login
Sonntag, 19.05.2024 Börsentäglich über 12.000 News von 688 internationalen Medien
GOLD-MINEN vor Jahrhundert-Hausse?! Diese Aktie sofort kaufen!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Edison Investment Research-Archiv vom 12.09.2023

ZeitNachrichten
Sprache: Alle DE EN
LeserMedien
12.09.23Melrose Industries - Clarity on GTF helpful for investors565The announcement about the expected impact of the GTF engine programme, in which Melrose has a 4% share, removes an uncertainty from the shares. The expected cost of £200m equates to 14p a share. While...
► Artikel lesen
12.09.23Respiri - Access platform-led growth prospects ahead307Respiri had a very active FY23, including the recent close of the Access Managed Services (Access) acquisition and the signing of several commercial contracts. These represent stepping stones to the...
► Artikel lesen
12.09.23JPMorgan European Discovery Trust - A balanced trust targeting a world-beating market307JPMorgan European Discovery Trust (JEDT) invests in European small-cap companies (excluding UK), with the aim of providing shareholders with long term capital growth. The investment case for this sector...
► Artikel lesen
12.09.23Murray International Trust - Business as usual at Murray International326The board of Murray International Trust (MYI) has been planning for manager Bruce Stout's end-June 2024 retirement for a long time. He and the trust's other two co-managers, Martin Connaghan and Samantha...
► Artikel lesen
12.09.23Seraphim Space Investment Trust - High demand for space tech's disruptive potential265Seraphim Space Investment Trust (SSIT) released its Q423 trading update to end-June 2023 yesterday, reporting that its top 10 holdings saw their revenues (weighted by portfolio fair value) increasing...
► Artikel lesen
12.09.23Oxford Cannabinoid Technologies - Clinical headway rests on funding291Oxford Cannabinoid Technologies (OCT) has shared its FY23 results and summarised its ongoing activities. OCT completed preclinical research for OCT461201 (programme 1) and in July 2023 the first healthy...
► Artikel lesen